Medicare Enrolled
Dr. Otakar Quadrat, MD
Interventional Cardiology · Daytona Beach, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Quadrat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quadrat? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quadrat
Dr. Otakar Quadrat is an interventional cardiology in Daytona Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Quadrat performed 11,224 Medicare services across 6,582 unique beneficiaries.
Between the years covered by Open Payments, Dr. Quadrat received a total of $24,489 from 53 pharmaceutical and/or device companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quadrat is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 6% volume in FL$ $24,489 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,224
Medicare services
Top 6% in FL for interventional cardiology
6,582
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~591 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,578 | $88 | $219 |
| Electrocardiogram (EKG), 12-lead | 1,493 | $10 | $37 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,249 | $43 | $120 |
| Echocardiogram, transthoracic | 842 | $140 | $500 |
| Hospital follow-up visit, moderate complexity | 718 | $63 | $148 |
| EKG interpretation and report | 617 | $6 | $40 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 601 | $315 | $800 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 377 | $27 | $70 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 320 | $54 | $141 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 311 | $20 | $69 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 301 | $1,163 | $2,907 |
| Anticoagulant management of patient taking warfarin | 283 | $9 | $24 |
| Nuclear medicine study of heart muscle blood flow by pet | 277 | $140 | $342 |
| Ultrasound of both sides of head and neck blood flow | 258 | $146 | $391 |
| Ultrasound of within the brain blood flow | 249 | $94 | $318 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 188 | $20 | $56 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 187 | $627 | $1,357 |
| Initial hospital admission, moderate complexity | 187 | $103 | $283 |
| New patient office visit (30-44 min) | 126 | $80 | $217 |
| Remote pacemaker/defibrillator monitoring, 90 days | 122 | $16 | $50 |
| Prothrombin time test (blood clotting) | 112 | $4 | $12 |
| Programming of cardiac rhythm monitor system | 89 | $40 | $107 |
| Programming of dual lead pacemaker system | 82 | $50 | $143 |
| Remote pacemaker monitoring, 90 days | 80 | $23 | $65 |
| Ultrasound scan of abdominal aorta | 73 | $103 | $223 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 66 | $19 | $69 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 57 | $15 | $31 |
| Evaluation of implantable heart and blood vessel monitoring system | 45 | $29 | $94 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 41 | $27 | $79 |
| Limited ultrasound scan behind abdominal cavity | 37 | $45 | $117 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 30 | $170 | $215 |
| Programming of dual lead implantable defibrillator system | 22 | $59 | $184 |
| Ultrasound of heart, follow-up | 22 | $65 | $194 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 22 | $19 | $52 |
| Initial hospital admission, high complexity | 20 | $138 | $414 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $81 | $306 |
| Office visit, established patient (20-29 min) | 19 | $63 | $151 |
| External shock to heart to regulate heart beat | 16 | $86 | $320 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $10 | $150 |
| Insertion of heart rhythm monitor under skin | 15 | $3,283 | $9,779 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 15 | $326 | $928 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $14 | $38 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $2 | $7 |
| Cardiac catheterization | 12 | $169 | $640 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.2% high complexity
25.1% medium
63.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,489
Total received (2018-2024)
Avg $3,498/year across 7 years
Top 22% in FL for interventional cardiology
53
Companies
724
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,240 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$249 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,658
2023$2,957
2022$3,078
2021$3,322
2020$1,527
2019$8,049
2018$2,896
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic Vascular, Inc.
$5,705
ABIOMED
$2,457
Janssen Pharmaceuticals, Inc
$1,868
Amgen Inc.
$1,430
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,423
AstraZeneca Pharmaceuticals LP
$1,251
Cardiovascular Systems Inc.
$1,056
Boston Scientific Corporation
$1,026
Novartis Pharmaceuticals Corporation
$807
SANOFI-AVENTIS U.S. LLC
$652
Novo Nordisk Inc
$598
E.R. Squibb & Sons, L.L.C.
$569
Medtronic, Inc.
$547
Alnylam Pharmaceuticals Inc.
$516
Esperion Therapeutics, Inc.
$471
CVRx, Inc.
$458
Amarin Pharma Inc.
$458
Merck Sharp & Dohme LLC
$384
PFIZER INC.
$376
Abbott Laboratories
$325
Penumbra, Inc.
$219
Bayer HealthCare Pharmaceuticals Inc.
$175
Shockwave Medical, Inc
$148
Edwards Lifesciences Corporation
$137
Cleerly, Inc.
$126
Lilly USA, LLC
$115
Kiniksa Pharmaceuticals, Ltd.
$87
LivaNova USA, Inc.
$84
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$72
Regeneron Healthcare Solutions, Inc.
$71
Lundbeck LLC
$70
Lexicon Pharmaceuticals, Inc.
$64
BOSTON SCIENTIFIC CORPORATION
$64
Daiichi Sankyo Inc.
$56
Opsens Inc.
$55
Kiniksa Pharmaceuticals International, plc
$52
Philips Electronics North America Corporation
$51
Kowa Pharmaceuticals America, Inc.
$46
Merck Sharp & Dohme Corporation
$43
CARDIVA MEDICAL, INC.
$43
Impulse Dynamics (USA) Inc.
$42
AngioDynamics, Inc.
$42
Braemar Manufacturing, LLC
$40
Bardy Diagnostics, Inc.
$39
PORTOLA PHARMACEUTICALS, INC.
$35
PORTOLA PHARMACEUTICALS, LLC
$31
Philips North America LLC
$21
Alexion Pharmaceuticals, Inc.
$18
iRhythm Technologies, Inc.
$17
Chiesi USA, Inc.
$16
Gilead Sciences, Inc.
$14
ARALEZ PHARMACEUTICALS US INC.
$11
Aziyo Biologics, Inc.
$8
Top 3 companies account for 41.0% of total payments
Associated products mentioned in payments ›
(7999) SRC Undivided · (CK7) Extended Holter · AMPLATZER AMULET · ANDEXXA · Arcalyst · Attain · Azure · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink Express · Carnation Ambulatory Monitor · Claria MRI · Cleerly Ischemia · Confirm Rx · Consulta · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · Diamondback Coronary · Diamondback Peripheral · ECM · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · FARXIGA · General - Vascular Access · HAWKONE · HawkOne · IN.PACT ADMIRAL · IN.PACT Admiral · INJECTAFER · Impella · Indigo System · Inpefa · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LINQ II · LOKELMA · LifeVest · Livalo · MICRA · MOUNJARO · MULTAQ · NEXLETOL · NEXLIZET · NORTHERA · NanoCross · ONPATTRO · ONYX FRONTIER · Optimizer · OptoWire · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PROTEKDUO · Peripheral Orbital Atherectomy System · QT Vascular Chocolate PTA Balloon · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · Repatha · Resolute · Reveal LINQ · SPIDERFX · SYNERGY · Saxenda · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRULICITY · VERQUVO · Vascepa · Vascular Closure Device · Vascular Lithotripsy · VersaCross Access Solution · Visia AF · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · ZIO Patch · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $218 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
15
Per 100K population
2.6
County median income
$66,581
Nearest hospital
HALIFAX HEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Quadrat is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Quadrat experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Quadrat performed 1,578 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quadrat receive payments from pharmaceutical companies?
Yes. Dr. Quadrat received a total of $24,489 from 53 companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quadrat's costs compare to other interventional cardiologys in Daytona Beach?
Dr. Quadrat's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quadrat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Daytona Beach
Browse interventional cardiologys in Daytona Beach ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology